D.C. Mun. Regs. tit. 22, r. 22-B1305

Current through Register Vol. 71, No. 52, December 27, 2024

Rule 22-B1305 - ISSUANCE OF CONTROLLED SUBSTANCE PRESCRIPTIONS

1305.1

The prescribing practitioner and the pharmacist shall be jointly responsible for compliance with this chapter in prescribing and dispensing a controlled substance.

1305.2

A prescription for a controlled substance shall be issued or dispensed only for a legitimate medical purpose by an individual practitioner acting in the usual course of his or her professional practice.

1305.3

A prescription for a controlled substance shall be issued for treatment of individual patients. A prescription for a controlled substance shall not be issued to an individual practitioner for general dispensing purposes.

1305.4

A prescription for a controlled substance listed in any schedule shall be used for the purpose of continuing the patient's dependency only when its issuance is pursuant to authorized clinical treatment in a narcotic treatment rehabilitation program.

1305.5

Any person issuing a prescription and any person knowingly filling a prescription which is not in conformity with this chapter shall be subject to the penalties provided for violations of the Act and this chapter.

1305.6

An order purporting to be a prescription issued not in the usual course of professional treatment or in legitimate and authorized research is not a prescription within the meaning and intent of the Act, and a person knowingly filling such a prescription, and the person issuing it, shall both be subject to the penalties provided for violations of the provisions of law relating to controlled substances.

D.C. Mun. Regs. tit. 22, r. 22-B1305

Final Rulemaking published at 33 DCR 1046, 1067 (February 21, 1986); as amended by Final Rulemaking published at 53 DCR 10055 (December 22, 2006)

Authority: Section 19(a)(3) of the District of Columbia Pharmacist and Pharmacy Regulation Act of 1980, effective September 16, 1980 (D.C. Law 3-98; D.C. Official Code § 47-2885.18.01(a)(3)); the District of Columbia Uniform Controlled Substances Act of 1981, effective August 5, 1981 (D. C. Law 4-29; D.C. Official Code § 48-901.01); Mayor's Order 98-48, dated April 15, 1998; Section 4902 of the Fiscal Year 2002 Budget Support Act of 2001, effective October 3, 2001 (D.C. Law 14-28; D.C. Official Code § 7-731); Section 15 of the District of Columbia Drug Manufacture and Distribution Licensure Act of 1990, effective June 13, 1990 (D.C. Law 8-137; D.C. Official Code § 48-714(a)); and Mayor's Order 98-88, dated May 29, 1998.